ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,5,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,10,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1,12,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,15,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,4,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2,6,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2,13,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,15,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
3,3,Hypoproteinaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
5,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
5,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
5,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
7,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
9,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
11,5,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
11,6,Diverticulum intestinal haemorrhagic,Diverticula,Diverticular disorders,Gastr,N
11,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,8,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11,9,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
11,10,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
13,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
13,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
13,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
13,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
14,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
14,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
14,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
15,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
15,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
16,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
16,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
16,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
16,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
16,7,Painful respiration,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
17,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
18,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
18,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
19,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
20,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
20,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
23,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
23,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
23,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
23,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
23,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
23,10,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
23,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
24,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
25,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
25,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
25,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
26,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
27,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
27,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
27,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
27,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
27,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
28,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
30,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
30,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
30,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
31,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
31,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
31,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
32,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
33,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
35,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
35,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
35,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
35,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
36,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
37,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
38,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
39,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
39,2,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
40,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
40,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
40,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
40,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
41,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
41,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
41,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
42,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
42,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
43,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,6,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
44,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
44,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
44,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
44,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
45,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
45,2,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
45,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
45,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
45,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
49,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
49,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
49,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
49,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
49,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
50,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
50,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
51,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
51,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
51,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
51,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
51,6,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
52,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
52,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
52,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
53,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
53,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
53,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
54,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
55,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
55,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
58,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
58,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
59,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
60,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
61,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
61,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
61,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
61,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
61,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
61,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
61,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
62,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
62,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
62,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
62,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
63,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
63,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
63,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,4,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
64,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
66,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
66,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
66,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,4,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
66,6,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
67,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
68,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
69,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
71,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
72,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
73,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
73,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
75,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,2,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
76,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
77,1,Crossmatch incompatible,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
77,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
77,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
78,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
78,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
79,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
80,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
80,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
80,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
80,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
81,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
82,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
83,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
83,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
83,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
83,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
83,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
84,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
84,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
85,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
85,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
85,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
86,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
86,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
87,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
87,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
88,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
88,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
88,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
89,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
89,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
89,3,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
89,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
89,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
89,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
89,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
90,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
91,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
92,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
93,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
93,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
94,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
94,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
94,3,Pathological fracture,Fractures NEC,Fractures,Musc,N
95,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
95,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
95,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
95,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
96,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,4,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
97,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
97,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
97,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
97,4,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
98,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
98,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
98,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
98,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
98,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
99,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
99,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
100,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
101,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
101,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
102,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
103,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
103,3,Headache,Headaches NEC,Headaches,Nerv,N
103,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
103,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
103,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
104,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
104,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
105,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
105,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
105,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
105,4,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
105,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
105,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
106,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
107,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
107,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
107,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
108,1,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
108,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
108,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
109,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
109,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
109,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
109,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
109,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
109,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
109,7,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
109,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
109,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
109,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
110,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
110,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
110,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
110,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
111,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
111,3,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
112,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
112,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
113,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
114,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
115,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
117,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
117,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
118,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
119,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
120,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
120,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
121,1,Blood immunoglobulin M,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
122,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,2,Lymphocyte transformation test,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
124,1,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
125,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
126,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
127,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
127,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
127,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
127,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
127,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
127,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
127,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
127,8,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
127,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
129,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
129,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
130,2,Crossmatch incompatible,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
131,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
131,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
131,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
132,1,Alanine aminotransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
133,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
133,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
134,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
135,1,Crossmatch incompatible,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
136,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
137,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
138,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
138,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
139,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
139,3,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
140,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
140,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
140,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
141,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
142,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
143,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
143,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
145,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
146,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
147,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
148,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
149,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
150,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
151,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
151,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
151,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
152,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
152,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
152,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
153,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
154,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
154,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
155,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
156,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
157,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
157,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
158,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
159,1,Axillary nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
160,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
161,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
162,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
163,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
164,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
165,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
166,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
167,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
168,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
168,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
168,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
168,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
168,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
168,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
168,10,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
169,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
170,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
171,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
172,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
172,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
174,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
174,2,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
175,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
175,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
175,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
176,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
177,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
177,2,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
178,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
179,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
180,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
180,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
180,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
181,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
181,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
182,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
183,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
183,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
183,3,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
183,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
184,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
184,3,Headache,Headaches NEC,Headaches,Nerv,N
184,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
184,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
185,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
186,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
187,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
187,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
188,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
189,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
189,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
189,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
190,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
190,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
190,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
191,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
193,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
194,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
195,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
196,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
196,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
196,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
196,5,Fungal test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
196,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
196,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
196,8,Respirovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
197,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
197,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
198,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
198,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
198,4,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
198,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
199,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
199,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
199,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
199,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
200,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
200,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
201,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
202,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
203,1,Microalbuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
204,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
204,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
204,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
205,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
205,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
205,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
206,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
206,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
207,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
208,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
209,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
209,3,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
210,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
210,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
210,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
211,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
211,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
212,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
213,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
213,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
214,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
214,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
215,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
215,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
216,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
216,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
217,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
217,2,Pharyngeal hypoaesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
218,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
218,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
219,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
219,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
220,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
221,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
222,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
223,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
224,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
225,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
225,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
226,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
227,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
227,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
228,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
228,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
228,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
229,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
229,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
229,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
229,4,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
230,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
230,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
230,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
230,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
230,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
230,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
231,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
231,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
232,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
232,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
232,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
233,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
234,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
235,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
235,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
236,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
236,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
236,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
236,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
236,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
237,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
237,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
237,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
238,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
238,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
239,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
239,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
239,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
239,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
240,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
241,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
241,3,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
241,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
242,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
242,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
243,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
243,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
244,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
244,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
245,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
245,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
246,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
246,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
246,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
246,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
246,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
246,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
246,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
247,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
249,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
250,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
250,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
251,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
252,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
253,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
253,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
254,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
255,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
256,1,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
256,2,Refraction disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
257,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
258,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
259,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
259,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
259,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
259,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
260,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,3,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
260,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
260,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
261,1,Headache,Headaches NEC,Headaches,Nerv,N
261,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
262,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
263,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
263,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
263,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
264,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
265,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
265,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
265,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
266,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
267,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
267,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
268,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
269,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
269,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
270,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
270,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
271,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
272,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
273,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
274,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
274,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,3,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
275,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
276,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
276,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
277,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
278,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
279,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
279,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
280,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
281,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
282,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
282,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
283,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
284,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
285,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
285,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
285,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
285,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
286,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
286,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
286,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
287,1,Tooth malformation,Dental developmental disorders and anomalies,Dental and gingival conditions,Gastr,N
288,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
288,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
288,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
289,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
290,1,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
291,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
293,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
293,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
293,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
293,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
295,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
297,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
297,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
297,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
297,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
298,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
299,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
299,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
300,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
300,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
300,3,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
300,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
301,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
301,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
302,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
303,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
304,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
304,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
305,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
306,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
306,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
307,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
307,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
310,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
310,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
311,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
313,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
314,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
314,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
314,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
314,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
315,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
316,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
316,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
316,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
316,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
316,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
316,6,Headache,Headaches NEC,Headaches,Nerv,N
316,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
316,8,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
316,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
316,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
316,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
317,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
317,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
318,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
319,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
319,2,Headache,Headaches NEC,Headaches,Nerv,N
319,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
320,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
320,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
320,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
321,1,Pseudomyopia,Refractive and accommodative disorders,Vision disorders,Eye,N
322,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
323,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
324,1,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
324,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
324,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
324,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
325,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
326,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
326,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
327,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
328,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
329,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
330,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
331,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
332,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
333,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
334,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
334,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
335,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
336,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
337,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
338,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
339,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
339,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
339,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
340,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
341,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
341,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
343,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
343,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
343,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
343,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
344,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
345,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
345,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
346,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
346,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
347,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
348,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
349,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
350,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
351,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
352,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
353,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
353,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
353,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
353,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
353,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
354,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
355,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
356,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
357,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
358,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
359,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
360,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
360,2,Pseudomyopia,Refractive and accommodative disorders,Vision disorders,Eye,N
361,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
361,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
362,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
363,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
363,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
363,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
363,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
363,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
363,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
363,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
364,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
365,1,Headache,Headaches NEC,Headaches,Nerv,N
366,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
368,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
368,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
368,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
369,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
370,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
370,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
370,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
370,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
370,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
371,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
371,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
371,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
371,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
371,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
371,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
371,7,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
372,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
372,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
373,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
374,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
374,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
374,3,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
375,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
376,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
377,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
377,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
377,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
377,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
377,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
377,7,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
377,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
377,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
377,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
377,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
377,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
377,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
377,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
377,15,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
377,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
377,17,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
377,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
378,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
378,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
379,1,Red blood cell agglutination,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
380,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
381,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
382,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
383,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
383,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
383,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
383,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
383,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
383,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
383,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
383,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
383,9,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
383,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
383,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
383,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
383,13,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,14,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
383,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
384,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
385,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
385,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
385,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
385,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
385,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
386,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
387,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
387,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
387,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
388,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
388,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
388,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
389,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
389,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
389,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
390,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
391,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
393,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
393,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
394,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
394,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
394,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
394,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
394,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
395,1,Aspiration bone marrow,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
395,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
395,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
395,4,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
396,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
396,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
396,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
396,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
396,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
397,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
397,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
397,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
398,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
398,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
398,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
398,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
398,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
399,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
400,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
400,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
401,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
401,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
401,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
403,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
403,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
404,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
404,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
404,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
405,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
405,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
406,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
407,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
408,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
409,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
410,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
411,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
411,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
411,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
411,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
411,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
411,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
412,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
413,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
